The following is a review of diagnostics related medical research worldwideThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.
The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
StratCom takes this opportunity to wish our readers
Research News for November 2003
Nanobac Pharmaceuticals, Inc. has discovered a link between nanobacteria and calcification in ovarian cancer patients. The discovery was published in the APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica) Journal; APMIS 111: 951-4, 2003.
An article in the New England Journal of Medicine has shown that glutathione peroxidase (GPx) is a strong predictor of the risk of cardiovascular events among the 636 patients studied. The GPx study concluded that low levels of glutathione peroxidase 1 activity are associated with increased risk of cardiovascular events in patients with coronary artery disease.
A clinical trial sponsored by Merck & Co. Inc. and Schering-Plough Corp. has shown that sitosterol is a member of a group of chemicals that scientists believe pose a possible risk for coronary heart disease. Sitosterol is similar to cholesterol and is absorbed from the intestine. The trial showed that even moderate levels of sitosterol in the bloodstream, in combination with high levels of LDL cholesterol were associated with nearly double the risk of a major heart problem than low amounts of sitosterol and high LDL.
Research News - October 2003
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links
Send mail to email@example.com with questions or comments about this web site.
Concept and Design Blue Page
Last modified: December 2, 2003